Search results for "thrombin"

showing 10 items of 201 documents

An aptamer-gated silica mesoporous material for thrombin detection.

2013

An aptamer-capped mesoporous material for the selective and sensitive detection of &-thrombin in human plasma and serum has been prepared and characterised.

INGENIERIA DE LA CONSTRUCCIONSilicon dioxideAptamerInorganic chemistryNanoparticleAptamersCatalysisFluorescencechemistry.chemical_compoundThrombinQUIMICA ORGANICAQUIMICA ANALITICAMaterials ChemistrymedicineElectrochemiluminescenceHumansHuman Alpha-ThrombinElectrochemiluminescenceMagnetic beadssilicon dioxidePropylaminesChemistryRhodaminesQUIMICA INORGANICAMetals and AlloysThrombinGeneral ChemistryAptamers NucleotideSilanesSilicon DioxideFluorescenceSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsSpectrometry FluorescenceHuman plasmaCeramics and CompositesNanoparticlesMesoporous materialNucleotidePorosityColorimetric detectionmedicine.drugNuclear chemistryChemical communications (Cambridge, England)
researchProduct

CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models

2021

BACKGROUND: CD248 is a pro-inflammatory, transmembrane glycoprotein expressed by vascular smooth muscle cells (VSMC), monocytes/macrophages, and other cells of mesenchymal origin. Its distribution and properties are reminiscent of those of the initiator of coagulation, tissue factor (TF). OBJECTIVE: We examined whether CD248 also participates in thrombosis. METHODS: We evaluated the role of CD248 in coagulation using mouse models of vascular injury, and by assessing its functional interaction with the TF-factor VIIa (FVIIa)-factor X (FX) complex. RESULTS: The time to ferric chloride-induced occlusion of the carotid artery in CD248 knockout (KO) mice was significantly longer than in wild-typ…

InflammationFactor VIIa030204 cardiovascular system & hematologyInferior vena cavaArticleThromboplastin03 medical and health sciencesTissue factorchemistry.chemical_compoundMice0302 clinical medicineThrombinTissue factor pathway inhibitorAntigens CDAntigens NeoplasmmedicineAnimalsHumansMice KnockoutVenous Thrombosismedicine.diagnostic_testFactor XHematologyCoagulationchemistrymedicine.veinCancer researchProthrombin Timemedicine.symptommedicine.drugPartial thromboplastin time
researchProduct

Signal transduction pathways involved in the mechanical responses to protease-activated receptors in rat colon.

2002

Recording simultaneously in vitro the changes of endoluminal pressure (index of circular muscle activity) and isometric tension (index of longitudinal muscle activity), we examined the mechanisms responsible for the apamin-sensitive relaxant and contractile responses induced by protease-activated receptor (PAR)-1 and PAR-2 activating peptides, SFLLRN-NH2 and SLIGRL-NH2, respectively, in rat colon. In the circular muscle, the inhibitory effects of SFLLRN-NH2 and SLIGRL-NH2 were significantly reduced by ryanodine, an inhibitor of Ca2+ release from the sarcoplasmic reticulum, but unaffected by 1-[6-[[17beta-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122), a phosph…

Intracellular FluidMalemedicine.medical_specialtyColonGenisteinBiologyIn Vitro Techniqueschemistry.chemical_compoundInternal medicinemedicineAnimalsReceptor PAR-2Receptor PAR-1Rats WistarReceptorProtein kinase CPharmacologyPhospholipase CRyanodine receptorNeural InhibitionRatsEndocrinologychemistryType C PhospholipasesMolecular MedicineCalciumReceptors ThrombinSignal transductionmedicine.symptomExtracellular SpaceTyrosine kinaseMuscle contractionMuscle ContractionSignal TransductionThe Journal of pharmacology and experimental therapeutics
researchProduct

Coagulation and fibrosis in chronic liver disease.

2008

In the hepatic tissue repair mechanism, hepatic stellate cells (HSCs) are recruited at the site of injury and their changes reflect paracrine stimulation by all neighbouring cell types, including sinusoidal endothelial cells, Kupffer cells, hepatocytes, platelets and leucocytes. Thrombin converts circulating fibrinogen to fibrin, promotes platelet aggregation, is a potent activator of endothelial cells, acts as a chemoattractant for inflammatory cells and is a mitogen and chemoattractant for fibroblasts and vascular smooth muscle cells. Most of the cellular effects elicited by thrombin are mediated via a family of widely expressed G-protein-coupled receptors termed protease activated recept…

Liver CirrhosisMaleKupffer CellsReceptors Proteinase-ActivatedThrombin liver fibrosisProteinase-ActivatedChronic liver diseaseFibrinLiver diseaseThrombinFibrosisReceptorsHepatic Stellate CellsmedicineAnimalsHumansPlateletReceptorBlood CoagulationWound HealingAnimals; Anticoagulants; Blood Coagulation; Chronic Disease; Disease Progression; Endothelial Cells; Female; Hepatic Stellate Cells; Hepatocytes; Humans; Kupffer Cells; Liver Cirrhosis; Liver Diseases; Male; Rats; Receptors Proteinase-Activated; Receptors Thrombin; Thrombin; Wound Healing; Gastroenterologybiologybusiness.industryLiver DiseasesThrombinGastroenterologyAnticoagulantsEndothelial Cellsmedicine.diseaseRatsChronic DiseaseImmunologyDisease ProgressionHepatocytesbiology.proteinHepatic stellate cellCancer researchFemaleReceptors Thrombinbusinessmedicine.drug
researchProduct

Survival and prognostic indicators in compensated and decompensated cirrhosis

1986

Six-year survival of cirrhosis was assessed in a series of 1155 consecutive patients (751 men, 404 women). Among the men, 33% were alcoholics and 18% were HBsAg positive; corresponding figures for the women were 15% and 6%, respectively. Features of decompensation at first presentation were observed in 63% of the patients. Six-year survival was 54% in compensated and 21% in decompensated patients. No significant differences in survival were found between alcoholics and nonalcoholics. Leading causes of death were liver failure (49%), hepatocellular carcinoma (22%), and bleeding (13%). The prognostic role of 21 variables was evaluated separately in compensated and decompensated patients by th…

Liver CirrhosisMaleRiskmedicine.medical_specialtyHBsAgCarcinoma HepatocellularCirrhosisPhysiologyGastroenterologySex FactorsEsophageal varicesLiver Cirrhosis AlcoholicInternal medicinemedicineHumansDecompensationProspective StudiesRetrospective StudiesProthrombin timeHepatitis B Surface Antigensmedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyMiddle AgedHepatologyPrognosismedicine.diseaseSurgeryHepatocellular carcinomaRelative riskRegression AnalysisFemalebusinessFollow-Up StudiesDigestive Diseases and Sciences
researchProduct

Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

2018

OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk factor for bleeding events. However, the relationship between platelet count and bleeding is still unclear. METHODS: We investigated the relationship between platelet count and major or clinical relevant nonmajor bleedings during a follow-up of ∼4 years. RESULTS: A total of 280 cirrhotic patients with different degrees of liver disease (67% males; age 64±37 years; 47% Child–Pugh B and C) were followed up for a median of 1,129 (interquartile range: 800–1,498) days yielding 953.12 patient-year of observation. The annual rate of any significant bleeding was 5.45%/year (3.57%/year and 1.8…

Liver CirrhosisMaleSettore MED/09 - Medicina Interna030204 cardiovascular system & hematologyGastroenterologySeverity of Illness IndexcjirrhosisACTIVATION0302 clinical medicineRisk FactorsMedicinePlateletProspective StudiesProspective cohort studyRISKAged 80 and overmedicine.diagnostic_testPRO-LIVERPlatelet cirrhosis gastrointestinal bleedingPlateletGastroenterologyASSOCIATIONMiddle AgedPrognosisItaly030211 gastroenterology & hepatologyFemaleGastrointestinal HemorrhageHumanAdultPlateletsmedicine.medical_specialtyPrognosiLiver CirrhosiMEDLINECOAGULATIONgastrointestinal bleedingSocio-culturaleHemorrhageHepatology; GastroenterologyFollow-Up Studie03 medical and health sciencesText miningInternal medicineSeverity of illnessENDOTOXEMIAPro-Liver StudyHumansHEMOSTASISInternational Normalized RatioAgedProportional Hazards ModelsProthrombin timeCirrhosiHepatologyPlatelet Count Bleeding Liver Cirrhosisbusiness.industryProportional hazards modelPlatelet CountRisk FactorcirrhosisHepatologybleedingThrombocytopeniaProspective StudieTHROMBOSISPlatelets cjirrhosis bleeding PRO-LIVERProportional Hazards ModelProthrombin TimebusinessDECOMPENSATED CIRRHOSISFollow-Up Studies
researchProduct

Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis

2005

AIM: To analyze the hepatic and intestinal microcirculation in an animal model of liver cirrhosis and inflammatory bowel disease (IBD) and to characterize the anti-inflammatory action of antithrombin III (ATIII) on leukocyte kinetics and liver damage. METHODS: Hepatic and intestinal microcirculation was investigated by intravital videomicroscopy. Standardized models of experimental chronic liver cirrhosis and bowel inflammation were employed. Animals were divided into four groups (n = 6/group): controls, animals with cirrhosis, animals with cirrhosis and IBD, animals with cirrhosis and IBD treated with ATIII. RESULTS: Cirrhosis facilitated leukocyte rolling and sticking in hepatic sinusoids…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisSerine Proteinase InhibitorsAntithrombin IIIInflammationInflammatory bowel diseaseGastroenterologyMicrocirculationEnteritisInternal medicineMedicineAnimalsRats WistarLiver injurybusiness.industryMicrocirculationAntithrombinGastroenterologyGeneral MedicineBlood flowmedicine.diseasedigestive system diseasesEnteritisRatsIntestinesLiverBrief Reportsmedicine.symptombusinessmedicine.drug
researchProduct

Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms

2005

Abstract Background. Prothrombin time is a benchmark for functional assessment in cirrhosis and Factor VII levels (FVII), crucial in determining the prothrombin time, are genetically determined. Methods. We have evaluated the prothrombin time, a number of haemostatic variables synthesised by the liver (FII, FV, FVII and activated FVII, AT and fibrinogen) and two polymorphisms of the FVII gene (5′F7 and 353R/Q) in: (a) patients with liver cirrhosis ( n  = 118), (b) patients with chronic hepatitis ( n  = 102) and (c) controls ( n  = 100). Results. By one-way analyses of variance, the prothrombin time and the mean levels of the FII, FV, FVIIc, FVIIa, and AT were statistically different between…

Liver Cirrhosismedicine.medical_specialtyCirrhosisGenotypeLiver CirrhosiFibrinogenChronic liver diseasechemistry.chemical_compoundhemic and lymphatic diseasesInternal medicineGenotypemedicineHumansAlleleAllele frequencyAllelesHepatitis ChronicProthrombin timeAllelePolymorphism GeneticHepatologyFactor VIImedicine.diagnostic_testbusiness.industryGastroenterologyFactor VIImedicine.diseaseEndocrinologychemistryCase-Control StudiesProthrombin TimebusinessCase-Control Studiemedicine.drugHuman
researchProduct

[Hemostatic effectiveness of TachoSil® patches in radiofrequency assisted minor hepatic resection].

2011

Aim. Intra- and postoperative bleeding represents an extremely serious and frequent complication of hepatic surgery. The aim of this study was to evaluate the effectiveness of TachoSil (R) to improve hemostasis in radiofrequency assisted minor hepatic resection. Methods. Between July 2008 and June 2010, 31 patients underwent radiofrequency assisted minor hepatic resection. At the end of the liver resection a sponge of TachoSil (R) was applied on the liver. Results. The mean intraoperative bleeding from the liver was 56.1 mL (range 0-300 mL). No patients received intra- and postoperative blood transfusion. Surgical drains were removed between the first and the sixth-eight postoperative day. …

Liver neoplasms surgery; Haemostasis; Liver diseasesAdultAged 80 and overMaleSurgical SpongesHemostatic TechniquesLiver DiseasesThrombinFibrinogenLiver neoplasms surgeryMiddle AgedCombined Modality TherapySettore MED/18 - Chirurgia GeneraleDrug CombinationsHaemostasiCatheter AblationHepatectomyHumansFemaleAgedMinerva chirurgica
researchProduct

Hemostatic, inflammatory, and oxidative markers in pesticide user farmers

2016

Research Article; International audience; The aim of this work was to investigate inflammatory, oxidative, and thrombotic parameters as biomarkers in farmers exposed to pesticides. Fifty farmers using chemical pesticides and 60 unexposed control men participated in this study. The Mediterranean diet compliance, the duration of pesticide use, and personal protection for pesticides handling were recorded using self-administered questionnaires. Serum biochemical parameters, oxidant/antioxidant, inflammatory, and thrombosis markers were determined. Our findings showed oxidative stress reflected by an increase in malondialdehyde, carbonyl proteins and superoxide anion levels and a decrease in vi…

Male0301 basic medicineAntioxidantHealth Toxicology and Mutagenesismedicine.medical_treatment[ SDV.TOX ] Life Sciences [q-bio]/ToxicologyClinical BiochemistryPhysiologyAscorbic AcidMetribuzin010501 environmental sciencesmedicine.disease_cause01 natural sciencesBiochemistryHemostaticsProtein Carbonylationchemistry.chemical_compoundOrganophosphateSuperoxidesimmune system diseasesMalondialdehydeSurveys and QuestionnairesVitamin Eoxidative stressStresspersistent organic pollutantsLymphocytesFarmersbiologyPersistent organic pollutantsfood and beveragesMiddle AgedCatalaseMalondialdehydeGlutathioneC-Reactive ProteinCatalaseMalathionProthrombinOxidation-ReductionResearch ArticleAdultAgricultural HealthStressExposureSuperoxide dismutase03 medical and health sciencesOccupational ExposuremedicineHumansPesticidespesticidethrombosis0105 earth and related environmental sciencesSuperoxide Dismutasebusiness.industryVitamin EFibrinogen[ SDV.BIO ] Life Sciences [q-bio]/BiotechnologyPesticideAscorbic acidrespiratory tract diseasesBiotechnologyLogistic Models030104 developmental biologychemistryinflammationIn-VitroSusceptibilitybiology.proteinbusinessBiomarkersOxidative stressBiomarkers
researchProduct